Moderna
MRNA
#1188
Rank
โ‚น1.292 T
Marketcap
โ‚น3,359
Share price
-0.43%
Change (1 day)
-55.67%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2024 (TTM): -โ‚น194.18 Billion

According to Moderna 's latest financial reports the company's current earnings are โ‚น5.05 Billion. In 2023 the company made an earning of -โ‚น332.94 Billion a decrease over its 2022 earnings that were of โ‚น819.02 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚น194.18 Billion-41.68%
2023 -โ‚น332.94 Billion-140.65%
2022 โ‚น819.02 B-27.81%
2021 โ‚น1.134 T-1911.15%
2020 -โ‚น62.64 Billion44.7%
2019 -โ‚น43.29 Billion28.63%
2018 -โ‚น33.66 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น3.53 Billion-98.22%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.276 T-742.89%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น3.57 Billion-98.21%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น15.94 Billion-91.98%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.085 T-646.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-โ‚น49.48 Billion-75.09%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.568 T-889.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น10.04 Billion-94.95%๐Ÿ‡บ๐Ÿ‡ธ USA